COMPLICACIONES MICROVASCULARES Y MACROVASCULARES DE LA DIABETES PDF

La prevalencia de complicaciones aumento: microvasculares, del 33,4 al 42,1%, y macrovasculares, del 22,3 al 37,2%. Los episodios finales mas frecuentes. la diabetes y de sus complicaciones micro y microvasculares, así como la . la hiperglucemia, reducir las complicaciones micro y macrovasculares a largo. mortalidad de la diabetes es debida al desarrollo de las complicaciones macrovasculares y microvasculares. Sin embargo, la neuropatía diabética genera más.

Author: Tur Jujora
Country: Guatemala
Language: English (Spanish)
Genre: Medical
Published (Last): 5 May 2018
Pages: 257
PDF File Size: 18.7 Mb
ePub File Size: 11.42 Mb
ISBN: 632-6-47216-968-6
Downloads: 43483
Price: Free* [*Free Regsitration Required]
Uploader: Zulucage

Adherencia terapéutica en pacientes con diabetes mellitus tipo 2 | Ramos Rangel | Revista Finlay

It is estimated that, fordiabetes mellitus affects million adult people globally, including Analizamos datos de 2. En hospitales normalmente es usada la intravenosa de dextrosa. Microvascular complications and risk factors in patients with type 2 diabetess. These specialists were invited at the discretion of the IDMPS participating physician for the evaluation of possible diabetes-related complications exclusively.

Inthe Center for the Americas at Vanderbilt University in the United States of America convened a work group to begin a collaborative project to increase access to preventive eye care in Latin America.

Solamente fueron identificadas investigaciones que analizaron complicaciones vasculares.

T2D patients macrovascu,ares insulin treatment were more frequently trained on diabetes than patients on OGLD alone, and more frequently trained than patients managed with diet and exercise only Table 3. Bull World Health Organ, 87pp. Diabetic retinopathy DRa specific vascular complication of diabetes, is the leading cause of blindness in workingage individuals in developed countries 2.

  ALEXANDRU BOLDUR ISTORIA BASARABIEI PDF

Continuing navigation will be considered as acceptance of this use. John Wiley lla Sons; N Engl J Med,pp. Effects of medical therapies on retinopathy progression in type 2 diabetes.

Bol Soc Peru Med Interna. In contrast, low-income nations from Latin America, Eastern Europe and Asia have a frequency of patients being at therapeutic goals that is comparable with the figures provided in the present Mexican report. The main limitations of this study are the cross-sectional design, the lack of standardized laboratory assays 29lack complicacoones standardized assessments of diabetes-related complications and the lack of random macrovssculares for both participating physicians and their patients.

[Characteristics of diabetes mellitus patients under a chronic disease program].

The prevalence of DR in Hispanic patients with diabetes longer than 15 years varies between DR is a common condition that often leads to permanent disability. Prevalence of systemic co-morbidities in patients with various grades of diabetic retinopathy.

Waist circumference, mean b. Are we doing enough? Eyes were unevenly affected in 38 patients Blindness was doubled in the affected patients. Parametric continuous variables are expressed as geometric means and standard deviations SDor minimum and maximum. Risk factors for diabetic retinopathy: Class of OGLD treatment. Cluster randomised controlled trial: In contrast, in high-income nations a transition toward better practice and quality of care delivered to patients with diabetes has been observed in the last years.

Last laboratory FBG value, mean b. An increased prevalence of DR was found in patients with any macro- or microvascular complication. Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. Frontiers of oral biology Rev Panam Salud Publica. Homocysteine and cardiovascular disease: The same prevalence of DR was found in women and men. Indian J Med Res [Internet].

  JOHANNES HIRSCHBERGER FILOSOFIA PDF

A DR prevalence of The participating physicians filled data in the paper CRF. The previously reported prevalence of DR was closer to that found in users of insulin or sulfonylureas in this study.

Int J Clin Pract, 63pp. DR was more prevalent in patients with arterial hypertension and in those with any macrovascular, neuropathic, or renal complication Figure 3. According to criteria of the American Diabetes Association, 1 had type 2 diabetes mellitus 15 Prevention of blindness from diabetes mellitus.

Optimized care reduces acute and long-term complications, while improving quality of life 9—17 diabetse but despite evidence-based guidelines, it is precisely in developing countries where diabetes is diagnosed late and standards of care are not completely followed as recommended. A great proportion of these Mexican patients with diabetes did not reach therapeutic targets. Diabetes Metab J [Internet]. The frequency of DR at diagnosis was 3.

The potential role of thiamine vitamin B1 in diabetic complications. complicacjones

Rev Aten Fam [revista en Internet].